Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 27Solid Tumors 15Advanced Solid Tumors 12Solid Tumor 10Advanced Solid Tumor 5Mesothelioma 3Carcinoma, Non-Small-Cell Lung 3Advanced Solid Tumours 3Triple Negative Breast Neoplasms 2Solid Tumor, Adult 2Neoplasms 2Mesothelioma, Malignant 2Carcinoma, Renal Cell 2Advanced Solid Tumour 2Advanced Solid Tumor Cancer 2Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor - Protocol Specific 1Unresectable Locally Advanced or Metastatic Solid Tumors 1Triple Negative Metastatic Breast Cancer 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor Cancer 1Small Cell Lung Carcinoma 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Recurrent Malignant Solid Neoplasm 1Prostatic Neoplasms 1Peritoneal Neoplasms 1

Interventions

tislelizumab 1Taxes 1Pemetrexed 1Paclitaxel 1Oxaliplatin 1Fluorouracil 1Etoposide 1Cisplatin 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced and Metastatic Solid Tumors × Paclitaxel × Other solid neoplasm × Clear all
NCT04047862 2025-08-22

Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

BeiGene

Phase 1 Completed
446 enrolled 49 charts
Other solid neoplasm

Locally Advanced and Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡